136 related articles for article (PubMed ID: 22427941)
21. Plasma Treatment Limits Cutaneous Squamous Cell Carcinoma Development In Vitro and In Vivo.
Pasqual-Melo G; Nascimento T; Sanches LJ; Blegniski FP; Bianchi JK; Sagwal SK; Berner J; Schmidt A; Emmert S; Weltmann KD; von Woedtke T; Gandhirajan RK; Cecchini AL; Bekeschus S
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708225
[TBL] [Abstract][Full Text] [Related]
22. NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5.
Gurri S; Siegenthaler B; Cangkrama M; Restivo G; Huber M; Saliba J; Dummer R; Blank V; Hohl D; Werner S
EMBO Mol Med; 2023 Nov; 15(11):e17761. PubMed ID: 37807968
[TBL] [Abstract][Full Text] [Related]
23. HSD17B7 gene in self-renewal and oncogenicity of keratinocytes from Black versus White populations.
Xu X; Tassone B; Ostano P; Katarkar A; Proust T; Joseph JM; Riganti C; Chiorino G; Kutalik Z; Lefort K; Dotto GP
EMBO Mol Med; 2021 Jul; 13(7):e14133. PubMed ID: 34185380
[TBL] [Abstract][Full Text] [Related]
24. The effect of 4-hexylresocinol administration on SCC-9 cells: mass spectrometric identification of proteins and cDNA microarray analysis.
Kang YJ; Kim SG
Maxillofac Plast Reconstr Surg; 2021 Aug; 43(1):28. PubMed ID: 34333710
[TBL] [Abstract][Full Text] [Related]
25. ACTN1 promotes malignant progression in cutaneous squamous cell carcinoma by downregulating the p53 signaling pathway.
Yuan T; Lu X; Jiang J; Chen N; Tang B; He C; Liu W; Wang J; Ci C
Chin Med J (Engl); 2024 Jun; ():. PubMed ID: 38835108
[No Abstract] [Full Text] [Related]
26. PHLDA1, a follicular stem cell marker, differentiates clear-cell/granular-cell trichoblastoma and clear-cell/granular cell basal cell carcinoma: a case-control study, with first description of granular-cell trichoblastoma.
Battistella M; Peltre B; Cribier B
Am J Dermatopathol; 2014 Aug; 36(8):643-50. PubMed ID: 23719479
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of TGF-β signaling, invasion, and growth of cutaneous squamous cell carcinoma by PLX8394.
Siljamäki E; Riihilä P; Suwal U; Nissinen L; Rappu P; Kallajoki M; Kähäri VM; Heino J
Oncogene; 2023 Dec; 42(49):3633-3647. PubMed ID: 37864034
[TBL] [Abstract][Full Text] [Related]
28. Super Enhancer-Regulated
Piipponen M; Riihilä P; Knuutila JS; Kallajoki M; Kähäri VM; Nissinen L
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010973
[TBL] [Abstract][Full Text] [Related]
29. RhoGDI1 interacts with PHLDA2, suppresses the proliferation, migration, and invasion of trophoblast cells, and participates in the pathogenesis of preeclampsia.
Song G; Jin F
Hum Cell; 2022 Sep; 35(5):1440-1452. PubMed ID: 35841528
[TBL] [Abstract][Full Text] [Related]
30. Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma.
Rahmati Nezhad P; Riihilä P; Knuutila JS; Viiklepp K; Peltonen S; Kallajoki M; Meri S; Nissinen L; Kähäri VM
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053469
[TBL] [Abstract][Full Text] [Related]
31. Effect of Taspine hydrochloride on the repair of rat skin wounds by regulating keratinocyte growth factor signal.
Wang X; Gao Y; Sun X
Bioengineered; 2022 Jan; 13(1):789-799. PubMed ID: 34898359
[TBL] [Abstract][Full Text] [Related]
32. Identification of potential immune-related circRNA-miRNA-mRNA regulatory network in cutaneous squamous cell carcinoma.
Wei Y; Yang X; Gao L; Yang J; Zheng L; Gao L; Zhou X; Xiang X; Zhang J; Yi C
Am J Cancer Res; 2021; 11(10):4826-4843. PubMed ID: 34765295
[TBL] [Abstract][Full Text] [Related]
33. Vascular Patterning as Integrative Readout of Complex Molecular and Physiological Signaling by VESsel GENeration Analysis.
Lagatuz M; Vyas RJ; Predovic M; Lim S; Jacobs N; Martinho M; Valizadegan H; Kao D; Oza N; Theriot CA; Zanello SB; Taibbi G; Vizzeri G; Dupont M; Grant MB; Lindner DJ; Reinecker HC; Pinhas A; Chui TY; Rosen RB; Moldovan N; Vickerman MB; Radhakrishnan K; Parsons-Wingerter P
J Vasc Res; 2021; 58(4):207-230. PubMed ID: 33839725
[TBL] [Abstract][Full Text] [Related]
34. CCR2 Mediates Chronic LPS-Induced Pulmonary Inflammation and Hypoalveolarization in a Murine Model of Bronchopulmonary Dysplasia.
Cui TX; Brady AE; Fulton CT; Zhang YJ; Rosenbloom LM; Goldsmith AM; Moore BB; Popova AP
Front Immunol; 2020; 11():579628. PubMed ID: 33117383
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases in keratinocyte carcinomas.
Riihilä P; Nissinen L; Kähäri VM
Exp Dermatol; 2021 Jan; 30(1):50-61. PubMed ID: 32869366
[TBL] [Abstract][Full Text] [Related]
36. Gene Expression Signatures Point to a Male Sex-Specific Lung Mesenchymal Cell PDGF Receptor Signaling Defect in Infants Developing Bronchopulmonary Dysplasia.
Fulton CT; Cui TX; Goldsmith AM; Bermick J; Popova AP
Sci Rep; 2018 Nov; 8(1):17070. PubMed ID: 30459472
[TBL] [Abstract][Full Text] [Related]
37. Transcriptionally inducible Pleckstrin homology-like domain, family A, member 1, attenuates ErbB receptor activity by inhibiting receptor oligomerization.
Magi S; Iwamoto K; Yumoto N; Hiroshima M; Nagashima T; Ohki R; Garcia-Munoz A; Volinsky N; Von Kriegsheim A; Sako Y; Takahashi K; Kimura S; Kholodenko BN; Okada-Hatakeyama M
J Biol Chem; 2018 Feb; 293(6):2206-2218. PubMed ID: 29233889
[TBL] [Abstract][Full Text] [Related]
38. Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition.
Ranieri D; Rosato B; Nanni M; Magenta A; Belleudi F; Torrisi MR
Oncotarget; 2016 Feb; 7(5):5440-60. PubMed ID: 26713601
[TBL] [Abstract][Full Text] [Related]
39. Matrilin-2, an extracellular adaptor protein, is needed for the regeneration of muscle, nerve and other tissues.
Korpos É; Deák F; Kiss I
Neural Regen Res; 2015 Jun; 10(6):866-9. PubMed ID: 26199591
[TBL] [Abstract][Full Text] [Related]
40. Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.
Finch PW; Mark Cross LJ; McAuley DF; Farrell CL
J Cell Mol Med; 2013 Sep; 17(9):1065-87. PubMed ID: 24151975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
